Total Equity - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Total Equity Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Total Equity
$2.5m
CAGR 3-Years
-73%
CAGR 5-Years
-52%
CAGR 10-Years
4%
Theratechnologies Inc
TSX:TH
Total Equity
-$23.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Total Equity
$212.1m
CAGR 3-Years
-10%
CAGR 5-Years
86%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Equity
$364.6m
CAGR 3-Years
3%
CAGR 5-Years
24%
CAGR 10-Years
22%
Covalon Technologies Ltd
XTSX:COV
Total Equity
CA$21.7m
CAGR 3-Years
34%
CAGR 5-Years
16%
CAGR 10-Years
13%
Spectral Medical Inc
TSX:EDT
Total Equity
-CA$22.8m
CAGR 3-Years
-265%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Portage Biotech Inc's Total Equity?
Total Equity
2.5m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Total Equity amounts to 2.5m USD.

What is Portage Biotech Inc's Total Equity growth rate?
Total Equity CAGR 10Y
4%

Over the last year, the Total Equity growth was -97%. The average annual Total Equity growth rates for Portage Biotech Inc have been -73% over the past three years , -52% over the past five years , and 4% over the past ten years .

Back to Top